Abstract:The objective of the present study was to examine whether Clostridium butyricum supplementation has a role in the regulation of the intestinal flora and the development of the immune system of neonatal mice. A total of 30 pregnant BALB/c mice, including their offspring, were randomly divided into three groups: In the maternal intervention group (Ba), maternal mice were treated with Clostridium butyricum from birth until weaning at postnatal day 21 (PD21) followed by administration of saline to the offspring at PD21-28; in the offspring intervention group (Ab), breast-feeding maternal mice were supplemented with saline and offspring were directly supplemented with Clostridium butyricum from PD21-28; in the both maternal and offspring intervention group (Bb), both maternal mice and offspring were supplemented with Clostridium butyricum at PD 0-21 and at PD21-28. While mice in the control group were given the same volume of normal saline. Stool samples from the offspring were collected at PD14, -21 and -28 to observe the intestinal flora by colony counts of Enterococcus spp., Enterobacter spp., Bifidobacterium spp. and Lactobacillus spp. Detection of intestinal secreted immunoglobulin A (sIgA) levels and serum cytokine (interferon-γ, and interleukin-12, -4 and -10) levels in offspring was performed to evaluate the effect on their immune system. The results revealed that compared with the control group, offspring in the Ba group displayed significantly decreased stool colony counts of Enterococcus spp. (t=3.123, P<0.01) at PD14 and significantly decreased counts of Enterobacter spp. at PD14 and -21 (t=2.563, P<0.05 and t=2.292, P<0.05, respectively). Compared with the control group, the stool colony counts of Bifidobacterium spp. and Lactobacillus spp. were significantly increased in the Ba group at PD21 (t=3.085, P<0.01 and t=2.8508, P<0.05, respectively). The Ab group had significantly higher stool colony counts of Bifidobacterium spp. and Lactobacillus spp. at PD28, compared with the control group (Q=7.679, P<0.01 and Q=6.149, P<0.01, respectively). There were no significant differences identified in the sIgA levels of the intestinal fluid and serum cytokine levels between the control group and the intervention groups. In conclusion, Clostridium butyricum administered to breast-feeding maternal mice was able to regulate the intestinal flora balance in their offspring. However, due to insignificant effects on sIgA level and the associated cytokines, Clostridium butyricum had a limited influence on the balance of type 1 vs. type 2 T-helper cells. However, using Clostridium butyricum as an invention may be a safe method for improving the balance of intestinal flora and associated processes in offspring.

Bifidobacterium longum Subsp. infantis Promotes IgA Level of Growing Mice in a Strain-Specific and Intestinal Niche-Dependent Manner

Sex-Dependent Modulation Of Immune Development In Mice By Secretory Iga-Coated Lactobacillus Reuteri Isolated From Breast Milk

Probiotics Induce Intestinal IgA Secretion in Weanling Mice Potentially Through Promoting Intestinal APRIL Expression and Modulating the Gut Microbiota Composition.

Impact of intestinal flora changes on the intestinal mucosal immunity in laboratory mice

Lactobacillus Rhamnosus Alters Intestinal IgA Levels and IgA–microbiota Interactions in Healthy Mice in a Strain-Specific Manner

Akkermansia Muciniphila Promotes SIgA Production and Alters the Reactivity Towards Commensal Bacteria in Early-Weaned Piglets

Oral administration of Bifidobacterium bifidum TMC3115 to neonatal mice may alleviate IgE-mediated allergic risk in adulthood.

Prevention of Atopic Dermatitis in Mice by <i>Lactobacillus Reuteri</i> Fn041 Through Induction of Regulatory T Cells and Modulation of the Gut Microbiota

The Effect of Bifidobacterium on Immunity and Intestinal Microflora of Normal Mouse

Supplementing Maternal Diet with Milk Oligosaccharides and Probiotics Helps Develop the Immune System and Intestinal Flora of Offsprings

Colonization of Segmented Filamentous Bacteria and Its Interaction with the Luminal IgA Level in Conventional Mice

Select Symbionts Drive High IgA Levels in the Mouse Intestine.

Infant Microbiota Communities and Human Milk Oligosaccharide Supplementation Independently and Synergistically Shape Metabolite Production and Immune Responses in Healthy Mice

IgA-mediated control of host-microbial interaction during weaning reaction influences gut inflammation

Effect of Clostridium Butyricum Supplementation on the Development of Intestinal Flora and the Immune System of Neonatal Mice

Enhancement of Innate Immune Function in Mice by Bifidobacterium bifidum FL-228.1

Dietary intervention with serum-derived bovine immunoglobulins protects barrier function in a mouse model of colitis

Effects of Age and Strain on the Microbiota Colonization in an Infant Human Flora-Associated Mouse Model

Increase in the Population of Duodenal Immunoglobulin A Plasmocytes in Axenic Mice Associated with Different Living or Dead Bacterial Strains of Intestinal Origin

IgA-Targeted Lactobacillus Jensenii Modulated Gut Barrier and Microbiota in High-Fat Diet-Fed Mice

Role of IgA in the Early-Life Establishment of the Gut Microbiota and Immunity: Implications for Constructing a Healthy Start